Neuroscience Section - The Obesity Society

The Challenges We Face: Obesity affects more than one billion people worldwide, contributing to an ever-increasing risk of cardiovascular disease, kidney disease, diabetes, and other related comorbidities. It is therefore incumbent upon healthcare providers across the globe to recognize obesity as a chronic, progressive disease and to provide compassionate, comprehensive care that improves the health and quality of life of those affected.

The target audience for this program includes health care providers (HCPs) who provide primary care to patients with obesity, as well as relevant specialist clinicians significantly involved in the management and treatment of obesity. These educational activities are intended for international healthcare professionals outside the US and the UK.

Live Webinar:

The GLP-1 Era: How Brain Science Is Reshaping Obesity Treatment

Date: Tuesday, June 30, 2026

Time: 12 – 1 pm ET

Description: Join The Obesity Society’s Neuroscience Section for an engaging webinar exploring how GLP-1 therapies have transformed obesity treatment and advanced our understanding of the brain’s role in regulating body weight.

This expert panel will discuss the obesity treatment landscape before and after GLP-1 medications, examine the neurobiology underlying their effects on brainstem, hypothalamic, and reward pathways, and explore emerging concepts such as “food noise” and other physiological drivers of eating behavior beyond hunger.

Featuring leading researchers from basic, translational, and clinical science, this timely discussion will provide insights into the neuroscience shaping the future of obesity treatment and research.

Accreditation Statement: XXX

Credit Designation Statement: XXX

Link: CLICK HERE TO WATCH

Featured panelists include:
Matthew Hayes, PhD
Martin Myers, MD, PhD
Anne Secher, PhD
Karolina Skibicka, PhD
Kevin Williams, PhD, FTO